Dietary fatty acid composition drives neuroinflammation and impaired behavior in obesity.

Anxiety Cognitive disorders High fat diet Hippocampus Hypothalamus Memory Neuroinflammation Obesity Polyunsaturated fatty acids ω6/ω3

Journal

Brain, behavior, and immunity
ISSN: 1090-2139
Titre abrégé: Brain Behav Immun
Pays: Netherlands
ID NLM: 8800478

Informations de publication

Date de publication:
01 Feb 2024
Historique:
received: 11 09 2023
revised: 17 01 2024
accepted: 20 01 2024
medline: 4 2 2024
pubmed: 4 2 2024
entrez: 3 2 2024
Statut: aheadofprint

Résumé

Nutrient composition in obesogenic diets may influence the severity of disorders associated with obesity such as insulin-resistance and chronic inflammation. Here we hypothesized that obesogenic diets rich in fat and varying in fatty acid composition, particularly in omega 6 (ω6) to omega 3 (ω3) ratio, have various effects on energy metabolism, neuroinflammation and behavior. Mice were fed either a control diet or a high fat diet (HFD) containing either low (LO), medium (ME) or high (HI) ω6/ω3 ratio. Mice from the HFD-LO group consumed less calories and exhibited less body weight gain compared to other HFD groups. Both HFD-ME and HFD-HI impaired glucose metabolism while HFD-LO partly prevented insulin intolerance and was associated with normal leptin levels despite higher subcutaneous and perigonadal adiposity. Only HFD-HI increased anxiety and impaired spatial memory, together with increased inflammation in the hypothalamus and hippocampus. Our results show that impaired glucose metabolism and neuroinflammation are uncoupled, and support that diets with a high ω6/ω3 ratio are associated with neuroinflammation and the behavioral deterioration coupled with the consumption of diets rich in fat.

Identifiants

pubmed: 38309640
pii: S0889-1591(24)00228-9
doi: 10.1016/j.bbi.2024.01.216
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Clara Sanchez (C)

Université Côte d'Azur, Institut de Pharmacologie Moléculaire et Cellulaire, CNRS, France.

Cécilia Colson (C)

Université Côte d'Azur, Institut de Pharmacologie Moléculaire et Cellulaire, CNRS, France; Université Côte d'Azur, Institut de Biologie de Valrose, CNRS, INSERM, France.

Nadine Gautier (N)

Université Côte d'Azur, Institut de Biologie de Valrose, CNRS, INSERM, France.

Pascal Noser (P)

Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Denmark.

Juliette Salvi (J)

Université Bourgogne Franche-Comté, Centre des Sciences du Goût et de l'Alimentation, CNRS, INRAe, France.

Maxime Villet (M)

Université Côte d'Azur, Institut de Pharmacologie Moléculaire et Cellulaire, CNRS, France.

Lucile Fleuriot (L)

Université Côte d'Azur, Institut de Pharmacologie Moléculaire et Cellulaire, CNRS, France.

Caroline Peltier (C)

Université Bourgogne Franche-Comté, Centre des Sciences du Goût et de l'Alimentation, CNRS, INRAe, France.

Pascal Schlich (P)

Université Bourgogne Franche-Comté, Centre des Sciences du Goût et de l'Alimentation, CNRS, INRAe, France.

Frédéric Brau (F)

Université Côte d'Azur, Institut de Pharmacologie Moléculaire et Cellulaire, CNRS, France.

Ariane Sharif (A)

Université de Lille, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neurosciences & Cognition, UMR-S 1172, Lille France.

Ali Altintas (A)

Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Denmark.

Ez-Zoubir Amri (EZ)

Université Côte d'Azur, Institut de Biologie de Valrose, CNRS, INSERM, France.

Jean-Louis Nahon (JL)

Université Côte d'Azur, Institut de Pharmacologie Moléculaire et Cellulaire, CNRS, France.

Nicolas Blondeau (N)

Université Côte d'Azur, Institut de Pharmacologie Moléculaire et Cellulaire, CNRS, France.

Alexandre Benani (A)

Université Bourgogne Franche-Comté, Centre des Sciences du Goût et de l'Alimentation, CNRS, INRAe, France.

Romain Barrès (R)

Université Côte d'Azur, Institut de Pharmacologie Moléculaire et Cellulaire, CNRS, France; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Denmark.

Carole Rovère (C)

Université Côte d'Azur, Institut de Pharmacologie Moléculaire et Cellulaire, CNRS, France. Electronic address: rovere@ipmc.cnrs.fr.

Classifications MeSH